BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Y, Chen H, Tsoi B, Wang Q, Shen J. Danggui-Shaoyao-San (DSS) Ameliorates Cerebral Ischemia-Reperfusion Injury via Activating SIRT1 Signaling and Inhibiting NADPH Oxidases. Front Pharmacol 2021;12:653795. [PMID: 33935765 DOI: 10.3389/fphar.2021.653795] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Cui X, Ma C, Yu Y, Li Z, Zhao L, Xiong H. Uncovering the effects and mechanism of Danggui Shaoyao San intervention on primary dysmenorrhea by serum metabolomics approach. J Chromatogr B Analyt Technol Biomed Life Sci 2022;1209:123434. [PMID: 36027705 DOI: 10.1016/j.jchromb.2022.123434] [Reference Citation Analysis]
2 Gong W, Wang K, Wang X, Chen Y, Qin X, Lu A, Guan D. Mathematical algorithm–based identification of the functional components and mechanisms in depression treatment: An example of Danggui-Shaoyao-San. Front Cell Dev Biol 2022;10:937621. [DOI: 10.3389/fcell.2022.937621] [Reference Citation Analysis]
3 Yang J, Li C, Liu Y, Han Y, Zhao H, Luo S, Zhao C, Jiang N, Yang M, Sun L. Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease. Front Pharmacol 2022;13:832299. [DOI: 10.3389/fphar.2022.832299] [Reference Citation Analysis]
4 Cheng X, Hu J, Liu X, Tibenda JJ, Wang X, Zhao Q. Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases. Front Pharmacol 2022;13:934256. [DOI: 10.3389/fphar.2022.934256] [Reference Citation Analysis]
5 Guo S, Li F, Wills M, Yip J, Wehbe A, Peng C, Geng X, Ding Y, Zhang F. Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway. Mediators of Inflammation 2022;2022:1-15. [DOI: 10.1155/2022/6886752] [Reference Citation Analysis]
6 Li N, Yu Y, Cui X, Liu Q, Xiong H. High-throughput UPLC-Q-TOF-MS/MS coupled with multivariable data processing approach for the rapid screening and characterization of chemical constituents and potential bioactive compounds from Danggui Shaoyao San. Biomed Chromatogr 2022;:e5420. [PMID: 35638160 DOI: 10.1002/bmc.5420] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li S, Yang Y, Zhang W, Li H, Yu W, Gao C, Xu J, Zhao W, Ren C. Systematic Understanding of Mechanism of Danggui Shaoyao San against Ischemic Stroke Using a Network Pharmacology Approach. Evid Based Complement Alternat Med 2022;2022:3747285. [PMID: 35035503 DOI: 10.1155/2022/3747285] [Reference Citation Analysis]
8 Wang C, Chen H, Jiang HH, Mao BB, Yu H. Total Flavonoids of Chuju Decrease Oxidative Stress and Cell Apoptosis in Ischemic Stroke Rats: Network and Experimental Analyses. Front Neurosci 2021;15:772401. [PMID: 34955724 DOI: 10.3389/fnins.2021.772401] [Reference Citation Analysis]
9 Fu X, Liu Q, Sun X, Chang H, Liu Y, Han J. Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San. J Alzheimers Dis 2021. [PMID: 34776439 DOI: 10.3233/JAD-210656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xie S, Jiang X, Doycheva DM, Shi H, Jin P, Gao L, Liu R, Xiao J, Hu X, Tang J, Zhang L, Zhang JH. Activation of GPR39 with TC-G 1008 attenuates neuroinflammation via SIRT1/PGC-1α/Nrf2 pathway post-neonatal hypoxic-ischemic injury in rats. J Neuroinflammation 2021;18:226. [PMID: 34645465 DOI: 10.1186/s12974-021-02289-7] [Reference Citation Analysis]